by Teresa Carroll | News and Updates
Therapies for Inherited Neuropathies team meets a key milestone and advances the development of therapeutics antibodies for the treatment of CMT1X. The laboratories of Rudolf Martini and Richard Stanley have previously reported the discovery of a novel biological... by Teresa Carroll | Research
An immune modulatory off-label approach for treating CMT1X The Martini laboratory has also initiated a program of evaluating drugs approved for other diseases for their possible use in treating CMT. The principle being followed is that drugs with demonstrated positive... by Teresa Carroll | News and Updates
“No man stands so tall as when he stoops to help a child” – Abraham Lincoln Celebrating Steve O’Donnell and his 2 decades of fundraising – from the 2021 CMTA Report Steve O’Donnell is a force of nature, as relentless as a hurricane and as... 
